Aurobindo Pharma reported INR580.8M in Ordinary Share Capital for its fiscal quarter ending in March of 2025.


Ordinary Share Capital Change Date
Cipla INR 1.62B 100K Mar/2025
Divis Laboratories Ltd 530M 0 Mar/2025
Dr.Reddys Laboratories INR 834M 0 Mar/2025
Hindustan Unilever INR 2.35B 0 Mar/2025
Sun Pharmaceuticals INR 2.4B 0 Mar/2025
UPL INR 1.59B 90M Mar/2025